Dabur India manufactures and sells ayurvedic medicines, baby care products, natural, herbal, personal health products and processed foods either directly or indirectly through its subsidiaries. It has had presence in Indian market for more than past 120 years. The company conduct its operations through six business units: family products, healthcare, ayurvedic specialities, pharmaceuticals, exports and miscellaneous products. The company`s is engaged in oral care products, health care product. The company`s other products include anti allergic & anti-cancer drugs and guar gum. It exports primarily to the Middle East through Redrock Limited. Dabur has plants situated at nine different locations in India. Dabur has six plants overseas including in Egypt, Nigeria, Dubai, Bangladesh and Nepal. It is also looking to commence manufacturing in Pakistan and Russia. It has been actively focusing on expanding its overseas business with emphasis on the South Asian markets and Russia. The company has undertaken massive restructuring over past few years and has exited from a number of low margin businesses. The company acquired Balsara Home Products in 2005 to boost up its product profile.
Dabur India Ltd is engaged in Personal Care business. Company is listed on both NSE and BSE. NSE symbol for Dabur India Ltd is 'DABUR' and BSE code for Dabur India Ltd is '500096'.